🇺🇸 FDA
Patent

US 8680263

Carbohydrate-based drug delivery polymers and conjugates thereof

granted A61KA61K38/10A61K38/16

Quick answer

US patent 8680263 (Carbohydrate-based drug delivery polymers and conjugates thereof) held by Nektar Therapeutics expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/10, A61K38/16, A61K38/28, A61K47/60